Schurr Paulus, Lentz Edda, Block Suzette, Kaifi Jussuf, Kleinhans Helge, Cataldegirmen Guellue, Kutup Asad, Schneider Claus, Strate Tim, Yekebas Emre, Izbicki Jakob
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
J Gastrointest Surg. 2008 Jul;12(7):1232-8. doi: 10.1007/s11605-008-0517-8. Epub 2008 Apr 30.
To date, the survival benefit of redo surgery in locally recurrent rectal adenocarcinoma remains unclear.
In an institutional study, operations for recurrence were retrospectively analyzed. Survival was calculated using the Kaplan-Meier plot and Cox regression analysis.
A total of 72 patients with local recurrence were explored or resected. In 38 patients, there was synchronous distant organ recurrence. Forty-five of 72 were re-resected and in 37 of 45 cases, R0 situations were achieved. In 11 of 38 metastasized patients, both local and distant organ recurrence were successfully removed. For obtaining tumor control, resections of inner genitals, bladder, and sacral bone were necessary in 10, 4, and 11 patients, respectively. Survival was better for patients re-resected with a median overall survival of 54.9 months, as compared with 31.1 months among non-resected patients (p = 0.0047, log-rank test). Subgroup analysis revealed that a benefit of re-resection was observed to a lesser extent in synchronous local and in distant disease. Cox analysis showed that initial Dukes stage and complete resections of local recurrences were independently determining prognosis (relative risk 1.762 and 0.689, p = 0.008 and p = 0.002, respectively).
Radical surgery for local recurrence can improve survival if complete tumor clearance is achieved, and concomitant distant tumor load should not principally preclude re-resection.
迄今为止,局部复发性直肠腺癌再次手术的生存获益仍不明确。
在一项机构研究中,对复发性手术进行回顾性分析。使用Kaplan-Meier曲线和Cox回归分析计算生存率。
共对72例局部复发患者进行了探查或切除。38例患者存在同步远处器官复发。72例患者中有45例接受了再次切除,其中45例中的37例达到了R0切除状态。38例转移患者中有11例成功切除了局部和远处器官复发灶。为实现肿瘤控制,分别有10例、4例和11例患者需要切除内生殖器、膀胱和骶骨。再次切除患者的生存率更高,中位总生存期为54.9个月,而非切除患者为31.1个月(p = 0.0047,对数秩检验)。亚组分析显示,在同步局部和远处疾病中,再次切除的获益程度较小。Cox分析表明,初始Dukes分期和局部复发的完整切除是独立的预后决定因素(相对风险分别为1.762和0.689,p = 0.008和p = 0.002)。
如果能实现肿瘤的完全清除,局部复发的根治性手术可提高生存率,并且同时存在的远处肿瘤负荷原则上不应排除再次切除。